Cargando…

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments

Despite the extensive research conducted in recent decades, the molecular mechanisms underlying major depressive disorder (MDD) and relative evidence-based treatments remain unclear. Various hypotheses have been successively proposed, involving different biological systems. This narrative review aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maffioletti, Elisabetta, Minelli, Alessandra, Tardito, Daniela, Gennarelli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564223/ https://www.ncbi.nlm.nih.gov/pubmed/32961910 http://dx.doi.org/10.3390/genes11091089

Ejemplares similares

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders
por: Maffioletti, Elisabetta, et al.
Publicado: (2014)

Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future
por: Maffioletti, Elisabetta, et al.
Publicado: (2021)

The effect of childhood trauma and trauma-focused psychotherapy on blood expression of MED22 in patients with major depressive disorder
por: Minelli, A., et al.
Publicado: (2022)

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients
por: Roulot, Morgane, et al.
Publicado: (2018)

The effect of childhood trauma and trauma-focused psychotherapy on blood expression in patients with major depressive disorder
por: Minelli, A., et al.
Publicado: (2021)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients
por: Maffioletti, Elisabetta, et al.
Publicado: (2021)

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
por: Minelli, Alessandra, et al.
Publicado: (2021)

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
por: Barlati, Stefano, et al.
Publicado: (2023)

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder
por: Milanesi, Elena, et al.
Publicado: (2012)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis
por: Brunoni, André Russowsky, et al.
Publicado: (2009)

Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis
por: Irwin, Courtney L., et al.
Publicado: (2023)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir, Süleyman, et al.
Publicado: (2015)

Network Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive Disorder
por: Zhang, Sha, et al.
Publicado: (2022)

Mechanism of saikogenin G against major depressive disorder determined by network pharmacology
por: Hu, Lili, et al.
Publicado: (2022)

Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder
por: Minelli, A, et al.
Publicado: (2015)

Neurobiological and pharmacological arguments for customization of cognitive behavioral psychotherapy in the treatment of major depressive disorder
por: Ristea, Silvia, et al.
Publicado: (2021)

The effectiveness of electroconvulsive therapy in substance use disorder at pharmacological treatment failure major depression
por: Dannon, P.
Publicado: (2023)

Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients
por: Grigoriou, Stefania S., et al.
Publicado: (2015)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Glial pharmacology in Asia & Beyond
por: Koizumi, Schuichi
Publicado: (2021)

How nutrients and natural products act on the brain: Beyond pharmacology
por: de Rus Jacquet, Aurelie, et al.
Publicado: (2023)

The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
por: Dattilo, Vincenzo, et al.
Publicado: (2020)

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment
por: Molendijk, M L, et al.
Publicado: (2011)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease
por: Taximaimaiti, Reyisha, et al.
Publicado: (2021)

Integrated network pharmacology and hepatic metabolomics to reveal the mechanism of Acanthopanax senticosus against major depressive disorder
por: Gu, Xinyi, et al.
Publicado: (2022)

The pharmacological management of depression
por: Kupfer, David J.
Publicado: (2005)

Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
por: Mathys, Monica
Publicado: (2018)

Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
por: Dogaru, Ioana-Alexandra, et al.
Publicado: (2022)

An Innovative Non-Pharmacologic Treatment for Delusional Misidentification in Persons with Major Neurocognitive Disorder
por: Adams, Anne E., et al.
Publicado: (2021)

Molecular Pharmacology
por: Mautner, Henry G.
Publicado: (1965)

Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
por: Eleftheriou, Georgios, et al.
Publicado: (2023)

Integrating Network Pharmacology, Molecular Docking and Pharmacological Evaluation for Exploring the Polyrhachis vicina Rogers in Ameliorating Depression
por: He, Junhui, et al.
Publicado: (2023)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
por: Minelli, A.
Publicado: (2022)

Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review
por: Brockbank, James, et al.
Publicado: (2021)

The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
por: Guerrera, Claudia Savia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bonfvhf5vod92a2ep1vd1mivk8